CTIC
  
  
      
        CTI BioPharma Corp. (DE) Common Stock
      
      
        
          CTIC
        
        
      
    
  
          CTIC
        
        
      Delisted
    CTIC was delisted on the 23rd of June, 2023.
55 hedge funds and large institutions have $126M invested in CTI BioPharma Corp. (DE) Common Stock in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 13 closing their positions.
New
  Increased
  Maintained
  Reduced
  Closed
  more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
24% less call options, than puts
Call options by funds: $443K | Put options by funds: $580K
46% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 13
    
      Holders
    
  
  
    
      
        
      
        55
      
    
      
    
  
    
      Holding in Top 10
    
  
  
    
      
        
      
        2
      
    
      
    
  
    
      Calls
    
  
  
    
      
        
      
        $443K
      
    
      
    
  
    
      Puts
    
  
  
    
      
        
      
        $580K
      
    
      
    
  
Top Buyers
| 1 | +$3.61M | |
| 2 | +$3.17M | |
| 3 | +$1.19M | |
| 4 | 
          
   
      Two Sigma Investments
     
    
      
      
        New York
      
     
   | 
        +$826K | 
| 5 | 
          
   
      Susquehanna International Group
     
    
      
        Bala Cynwyd,
      
      
        Pennsylvania
      
     
   | 
        +$646K | 
Top Sellers
| 1 | -$5.82M | |
| 2 | -$3.59M | |
| 3 | -$966K | |
| 4 | 
          
   
    EI
   
  
      EAM Investors
     
    
      
        Solana Beach,
      
      
        California
      
     
   | 
        -$773K | 
| 5 | 
          
   
      Renaissance Technologies
     
    
      
      
        New York
      
     
   | 
        -$548K |